Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss.
Clark
Christine A
CA
LifeQuest Centre for Reproductive; Medicine and Mt. Sinai Hospital, Toronto, Ontario, Canada (Clark, Spitzer) University of Toronto, LifeQuest; Centre for Reproductive Medicine and Mt. Sinai Hospital, Toronto, Ontario, Canada (Laskin) McMaster Medical Centre, Hamilton,Ontario Canada (Crowther, Ginsberg).
Spitzer
Karen A
KA
Laskin
Carl A
CA
Crowther
Mark R
MR
Ginsberg
Jeff S
JS
D000026:Abortion, Habitual / Q000453:epidemiology / Q000276:immunology*; D017153:Antibodies, Anticardiolipin / Q000032:analysis*; D000925:Anticoagulants / Q000008:administration & dosage; D016736:Antiphospholipid Syndrome / Q000188:drug therapy*; D001241:Aspirin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006493:Heparin / Q000008:administration & dosage*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D050498:Live Birth; D015201:Meta-Analysis as Topic; D011247:Pregnancy
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D001241:Aspirin